{"pageContent": "Purpose: SEER recently released patient Gleason scores at biopsy/transurethral resection of the prostate. For the first time this permits accurate assessment of prostate cancer presentation and treatment according to clinical factors at diagnosis.", "metaData": {"source": "Targeting angiogenesis for the treatment of prostate cancer\nhttps://pubmed.ncbi.nlm.nih.gov/22413953/"}}